0001021432-18-000400.txt : 20181130
0001021432-18-000400.hdr.sgml : 20181130
20181130121311
ACCESSION NUMBER: 0001021432-18-000400
CONFORMED SUBMISSION TYPE: 15-12G
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20181130
DATE AS OF CHANGE: 20181130
EFFECTIVENESS DATE: 20181130
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Comet Trail Acquisition Corp
CENTRAL INDEX KEY: 0001743722
STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770]
IRS NUMBER: 830673433
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 15-12G
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-55944
FILM NUMBER: 181210462
BUSINESS ADDRESS:
STREET 1: 9454 WILSHIRE BLVD STE 612
CITY: BEVERLY HILLS
STATE: CA
ZIP: 90212
BUSINESS PHONE: 3108881870
MAIL ADDRESS:
STREET 1: 9454 WILSHIRE BLVD STE 612
CITY: BEVERLY HILLS
STATE: CA
ZIP: 90212
15-12G
1
form15comettrail.txt
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER
SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION
OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934.
Commission File Number: 000-55944
COMET TRAIL ACQUISITION CORPORATION
(Exact name of registrant as specified in its charter)
9454 Wilshire Boulevard, Suite 610
Beverly Hills, California 90212
310-888-1870
(Address, including zip code, and telephone number, including area
code, of registrant's principal executive offices)
Common Stock
(Title of each class of securities covered by this Form)
None
(Titles of all other classes of securities for which a duty to
file reports under Section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate
rule provision(s) relied upon to terminate or suspend the duty to
file reports:
Rule 12g-4(a)(1) / X /
Rule 12g-4(a)(2) /__/
Rule 12h-3(b)(1)(i) / X /
Rule 12h-3(b)(1)(ii) /__/
Rule 15d-6 /__/
Approximate number of holders of record as of the certification or
notice date: 2 (number of shareholders)
Pursuant to the requirements of the Securities Exchange Act of
1934, MQ MEDICAL TECHNOLOGIES CORP. has caused this certification/
notice to be signed on its behalf by the undersigned duly authorized
person.
Date: November 29, 2018 By: /s/ James Cassidy
James Cassidy
President